Ftse Mib
34.374,77
0,00%
DAX
20.024,66
0,58%
S&P 500
5.868,55
-0,22%
NASDAQ
19.280,79
-0,16%
Bitcoin
96.478,72
-0,43%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Amphastar Pharmaceuticals Inc (AMPH) Amphastar Pharmaceuticals Inc (AMPH) Notizie

AMPH

Amphastar Pharmaceuticals (AMPH)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AMPH
DataOraFonteTitoloSimboloCompagnia
16/12/202423:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
12/11/202419:29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
07/11/202422:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AMPHAmphastar Pharmaceuticals Inc
06/11/202422:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMPHAmphastar Pharmaceuticals Inc
29/02/202422:53Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AMPHAmphastar Pharmaceuticals Inc
09/02/202423:21Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AMPHAmphastar Pharmaceuticals Inc
12/09/202318:10Dow Jones NewsAmphastar Pharmaceuticals Shares Down 9% After Private Notes OfferingNASDAQ:AMPHAmphastar Pharmaceuticals Inc
16/08/202323:24Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:AMPHAmphastar Pharmaceuticals Inc
21/06/202323:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
15/06/202322:08Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
06/06/202312:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
09/05/202322:55Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
24/04/202313:42Dow Jones NewsEli Lilly to Sell Baqsimi Product to AmphastarNASDAQ:AMPHAmphastar Pharmaceuticals Inc
24/04/202312:45PR Newswire (US)Lilly to Divest BAQSIMI to AmphastarNASDAQ:AMPHAmphastar Pharmaceuticals Inc
14/04/202322:22Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
14/04/202322:10Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
01/03/202322:14Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
09/02/202317:09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
09/08/202212:55TipRanksNeedham Sticks to Its Hold Rating for Amphastar Pharmaceuticals (AMPH)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
09/06/202220:05TipRanksAmphastar Pharmaceuticals (AMPH) Receives a Hold from NeedhamNASDAQ:AMPHAmphastar Pharmaceuticals Inc
24/05/202218:25TipRanksNeedham Maintains a Hold Rating on Amphastar Pharmaceuticals (AMPH)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
14/04/202222:32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
13/04/202217:35TipRanksNeedham Maintains Their Hold Rating on Amphastar Pharmaceuticals (AMPH)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
08/04/202216:45TipRanksAmphastar Pharmaceuticals (AMPH) Gets a Hold Rating from NeedhamNASDAQ:AMPHAmphastar Pharmaceuticals Inc
09/11/202122:34Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
15/06/202122:05GlobeNewswire Inc.Amphastar Pharmaceuticals to Present at the Raymond James Human Health Innovation ConferenceNASDAQ:AMPHAmphastar Pharmaceuticals Inc
27/05/202112:00GlobeNewswire Inc.Amphastar Pharmaceuticals to Present at the Jefferies Virtual Healthcare ConferenceNASDAQ:AMPHAmphastar Pharmaceuticals Inc
07/05/202122:05GlobeNewswire Inc.Amphastar Announces Buyback of 26% of the Equity in its ANP Subsidiary and Spin-off its Hanxin SubsidiaryNASDAQ:AMPHAmphastar Pharmaceuticals Inc
06/05/202122:05GlobeNewswire Inc.Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2021NASDAQ:AMPHAmphastar Pharmaceuticals Inc
03/05/202112:00GlobeNewswire Inc.Amphastar Pharmaceuticals Receives FDA Approval for Morphine Sulfate InjectionNASDAQ:AMPHAmphastar Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AMPH

La tua Cronologia

BIT
S27013
Societe Generale Effekten
TG
MOS
Orange Belgium
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network